Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67591193
Model No.: DM 475086-75-0
Productivity: Stock available
Transportation: Ocean,Air
Place of Origin: Hebei,China
Supply Ability: As per order
Certificate: ISO9001
Port: Shanghai,Shenzhen,Qingdao
Payment Type: L/C,T/T,D/P
Incoterm: FOB,CIF
High quality Selexipag Intermediate CAS No 475086-75-0:
CAS No.: 475086-75-0
Name: Selexipag Intermediate
MF: C23H27N3O
Molecular Weight 361.47998
Appearance White Powder
Purity 99% Min
Selexipag (brand name Uptravi) is a drug developed by Actelion for the treatment of pulmonary arterial hypertension (PAH). Selexipag and its active metabolite, ACT-333679 (or MRE-269, the free carboxylic acid), are agonists of the prostacyclin receptor, which leads to vasodilation in the pulmonary circulation.
Our productions of Selexipag Intermediates:
Picture of Selexipag Intermediate CAS No 475086-75-0:
Product Categories : APIs And Intermediates > Selexipag Intermediates
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Contact Now